8rij
From Proteopedia
(Difference between revisions)
Line 1: | Line 1: | ||
- | '''Unreleased structure''' | ||
- | + | ==Discovery of the first orally bioavailable ADAMTS7 inhibitor BAY-9835== | |
- | + | <StructureSection load='8rij' size='340' side='right'caption='[[8rij]], [[Resolution|resolution]] 1.96Å' scene=''> | |
- | + | == Structural highlights == | |
- | + | <table><tr><td colspan='2'>[[8rij]] is a 1 chain structure with sequence from [https://en.wikipedia.org/wiki/Homo_sapiens Homo sapiens]. Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=8RIJ OCA]. For a <b>guided tour on the structure components</b> use [https://proteopedia.org/fgij/fg.htm?mol=8RIJ FirstGlance]. <br> | |
- | + | </td></tr><tr id='method'><td class="sblockLbl"><b>[[Empirical_models|Method:]]</b></td><td class="sblockDat" id="methodDat">X-ray diffraction, [[Resolution|Resolution]] 1.96Å</td></tr> | |
- | [[Category: | + | <tr id='ligand'><td class="sblockLbl"><b>[[Ligand|Ligands:]]</b></td><td class="sblockDat" id="ligandDat"><scene name='pdbligand=A1H07:~{N}-[[(4~{R})-4-cyclopropyl-2,5-bis(oxidanylidene)imidazolidin-4-yl]methyl]-2-(3-fluorophenyl)-1,2,3-triazole-4-carboxamide'>A1H07</scene>, <scene name='pdbligand=CA:CALCIUM+ION'>CA</scene>, <scene name='pdbligand=CL:CHLORIDE+ION'>CL</scene>, <scene name='pdbligand=PEG:DI(HYDROXYETHYL)ETHER'>PEG</scene>, <scene name='pdbligand=ZN:ZINC+ION'>ZN</scene></td></tr> |
+ | <tr id='resources'><td class="sblockLbl"><b>Resources:</b></td><td class="sblockDat"><span class='plainlinks'>[https://proteopedia.org/fgij/fg.htm?mol=8rij FirstGlance], [http://oca.weizmann.ac.il/oca-bin/ocaids?id=8rij OCA], [https://pdbe.org/8rij PDBe], [https://www.rcsb.org/pdb/explore.do?structureId=8rij RCSB], [https://www.ebi.ac.uk/pdbsum/8rij PDBsum], [https://prosat.h-its.org/prosat/prosatexe?pdbcode=8rij ProSAT]</span></td></tr> | ||
+ | </table> | ||
+ | == Function == | ||
+ | [https://www.uniprot.org/uniprot/MMP12_HUMAN MMP12_HUMAN] May be involved in tissue injury and remodeling. Has significant elastolytic activity. Can accept large and small amino acids at the P1' site, but has a preference for leucine. Aromatic or hydrophobic residues are preferred at the P1 site, with small hydrophobic residues (preferably alanine) occupying P3. | ||
+ | __TOC__ | ||
+ | </StructureSection> | ||
+ | [[Category: Homo sapiens]] | ||
+ | [[Category: Large Structures]] | ||
+ | [[Category: Beyer K]] | ||
+ | [[Category: Broehl A]] | ||
+ | [[Category: Cancho-Grande Y]] | ||
+ | [[Category: Elowe N]] | ||
+ | [[Category: Henninger K]] | ||
+ | [[Category: Johannes S]] | ||
+ | [[Category: Jungmann N]] | ||
+ | [[Category: Krainz T]] | ||
+ | [[Category: Lindner N]] | ||
+ | [[Category: Maassen S]] | ||
+ | [[Category: MacDonald B]] | ||
+ | [[Category: Meibom D]] | ||
+ | [[Category: Menshykau D]] | ||
+ | [[Category: Mittendorf J]] | ||
+ | [[Category: Sanchez G]] | ||
+ | [[Category: Schafer M]] | ||
+ | [[Category: Stefan E]] | ||
+ | [[Category: Torge A]] | ||
+ | [[Category: Wasnaire P]] | ||
+ | [[Category: Xing Y]] | ||
+ | [[Category: Zubov D]] |
Revision as of 08:57, 21 February 2024
Discovery of the first orally bioavailable ADAMTS7 inhibitor BAY-9835
|
Categories: Homo sapiens | Large Structures | Beyer K | Broehl A | Cancho-Grande Y | Elowe N | Henninger K | Johannes S | Jungmann N | Krainz T | Lindner N | Maassen S | MacDonald B | Meibom D | Menshykau D | Mittendorf J | Sanchez G | Schafer M | Stefan E | Torge A | Wasnaire P | Xing Y | Zubov D